World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
Research and Development (R&D) approaches of pharmaceutical companies Pfizer and Glaxo with smaller budgets and smaller units
07/01/2010
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Glaxo Tries Biotech Model to Spur Drug InnovationsWall Street Journal 07/01/2010
The different approaches of Pfizer and Novartis for new drug research and development in 2009-2015
06/11/2009
Working with smaller R&D budgets and focussing the research on a few areas, collaboration with universities, and other ways to get more out of the R&D dollar.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Novartis: Radically Remaking Its Drug BusinessBusinessWeek 06/11/2009
Roche's integration of Genentech into its operations.
07/24/2008
During the early stages of the acquisition of Genentech questions were raised whether the bigger Swiss compay would end up stifling the research culture at Gennetech and reaearch scientists woul leave. As it turned out few have left and Roche head Severin Schwan has committed Roche to focussing on research as ahuge opportunity for pharmaceuticals as he sees drugmaking still "so crude," and the opportunities vast with advances in biotechnology, diagnostics, and genomics.
Linked Articles
Economist 12/10/2009
Roche's Big Hurdle with GenentechBusinessWeek 07/24/2008
U.S. president Obama, lobbyists and the 2010 Obama health care law
07/24/2009
The political process and the influence of lobbyists on Congress and the White House constrains the development of laws that control healthcare costs. Higher health care costs means less money for infrastructure development, education, research and development funding, and other priorities which build a future for Americans.
Linked Articles
E-Mails Highlight Extent of Obama's Deal With Industry on Health Care
New York Times 06/08/2012
Obama's Health Expert Gets PoliticalWall Street Journal 07/24/2009
Warnings on energy by Stewart Udall, interior secretary under John Kennedy.
11/16/2008
Innovative public transportations systems that the automakers could do research and development to develop.
Linked Articles
Have You Driven a Bus or a Train Lately?
New York Times 11/16/2008
How High Gas Prices Can Save the Car IndustryNew York Times 11/16/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us